Outset Medical, Inc. (OM)
NASDAQ: OM · Real-Time Price · USD
4.300
+0.120 (2.87%)
Aug 19, 2026, 10:00 AM EDT - Market open

Outset Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-74.29-81.65-127.98-172.8-162.96-131.94
Depreciation & Amortization
3.314.345.735.815.175.16
Loss (Gain) From Sale of Assets
00.010.050.110.04-
Loss (Gain) From Sale of Investments
-2.02-2.25-4.72-6.370.451.97
Stock-Based Compensation
15.2915.6229.3638.6327.217.45
Provision & Write-off of Bad Debts
2.633.522.370.18--
Other Operating Activities
4.5711.94.573.835.472.7
Change in Accounts Receivable
3.043.78-5.01-5.09-2.51-19.14
Change in Inventory
4.5911.79-10.861.65-14.73-22.04
Change in Accounts Payable
3.04-3.29-1.955.31-1.28-3.07
Change in Unearned Revenue
-0.250.61.773.022.162.88
Change in Other Net Operating Assets
1.76-10.68-9.64-5.65-4.7915.76
Operating Cash Flow
-38.32-46.33-116.3-131.37-145.73-130.26
Operating Cash Flow Growth
------
Capital Expenditures
-0.56-0.8-0.91-3.44-8.33-3.11
Investment in Securities
34.18-96.89104.8586.47-57.97-139.4
Investing Cash Flow
33.62-97.68103.9483.03-66.3-142.51
Long-Term Debt Issued
-98.2766.5233.2396.06-
Long-Term Debt Repaid
--204.95---31.2-
Net Debt Issued (Repaid)
-0.09-106.6866.5233.2364.86-
Issuance of Common Stock
0.740.642.2810.438.04160.15
Other Financing Activities
---0.94---
Financing Cash Flow
0.6455.567.8743.6572.9160.15
Net Cash Flow
-4.05-88.5155.51-4.7-139.13-112.62
Free Cash Flow
-38.88-47.13-117.22-134.81-154.05-133.37
Free Cash Flow Growth
------
Free Cash Flow Margin
-33.00%-39.44%-103.10%-103.40%-133.53%-129.99%
Free Cash Flow Per Share
-2.13-3.10-33.85-40.79-47.98-43.88
Levered Free Cash Flow
-14.68-21.35-69.93-70.09-94.56-87.69
Unlevered Free Cash Flow
-6.1-12.63-55.01-62.17-92.33-86.61
Cash Interest Paid
10.8715.6320.6910.853.191.15
Cash Income Tax Paid
0.910.450.590.490.390.08
Change in Working Capital
12.192.2-25.69-0.77-21.14-25.6
SEC Filings: 10-K · 10-Q